Kraemer, Moritz U.G., Faria, Nuno R., Reiner, Robert C., Golding, Nick, Nikolay, Birgit, Stasse, Stephanie, Johansson, Michael A., Salje, Henrik, Faye, Ousmane, Wint, G.R. William, Niedrig, Matthias, Shearer, Freya M., Hill, Sarah C., Thompson, Robin N., Bisanzio, Donal, Taveira, Nuno, Nax, Heinrich, Pradelski, Bary S.R., Nsoesie, Elaine O., Murphy, Nicholas R., Bogoch, Isaac I., Khan, Kamran, Brownstein, John S., Tatem, Andrew J., de Oliveira, Tulio, Smith, David L., Sall, Amadou A., Pybus, Oliver G., Hay, Simon I., Cauchemez, Simon, University of Oxford, University of Washington [Seattle], Li Ka Shing Centre for Health Information and Discovery [Oxford, UK], University of Melbourne, Modélisation mathématique des maladies infectieuses - Mathematical modelling of Infectious Diseases, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Centre de Bioinformatique, Biostatistique et Biologie Intégrative (C3BI), Centers for Disease Control and Prevention [San Juan], Centers for Disease Control and Prevention, Johns Hopkins Bloomberg School of Public Health [Baltimore], Johns Hopkins University (JHU), Arbovirus et Virus de Fièvres Hémorragiques [Dakar, Sénégal], Institut Pasteur de Dakar, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Department of Zoology [Oxford], Robert Koch Institute [Berlin] (RKI), Instituto Superior de Ciências da Saúde Egas Moniz [Portugal], Université de Lisbonne, Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich] (ETH Zürich), University of California [San Francisco] (UC San Francisco), University of California (UC), Toronto General Hospital Research Institute [Canada] (TGHRI), Keenan Research Centre of the Li Ka Shing Knowledge Institute [Toronto], Harvard University, Flowminder Foundation, University of Southampton, University of KwaZulu-Natal [Durban, Afrique du Sud] (UKZN), Department of Zoology, MUGK receives funding from the International research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS, European Commission 7th Framework Programme [ 21893 ]). NG is supported by a University of Melbourne McKenzie fellowship . MAJ received partial support from the Models of Infectious Disease Agent Study program (Cooperative Agreement number 1U54GM088558 ). FMS acknowledges funding from the Rhodes Trust . SIH received a grant from the Research for Health in Humanitarian Crises (R2HC) Programme, managed by ELRHA (number 13468 ), which also supported MUGK. The Research for Health in Humanitarian Crises (R2HC) programme aims to improve health outcomes by strengthening the evidence base for public health interventions in humanitarian crises. The £8 million R2HC programme is funded equally by the Wellcome Trust and Department for International Development , with Enhancing Learning and Research for Humanitarian Assistance (ELRHA) overseeing the programme's execution and management. TdO is funded by a Flagship Grant from the Medical Research Council (MRC) of the Republic of South Africa ( MRC-RFA-UFSP-01-2013/UKZN HIVEPI ), by the VIROGENESIS project European Union's Horizon 2020 (number 634650 ), and a Royal Society Newton Advanced Fellowship . SIH is funded by a Senior Research Fellowship from the Wellcome Trust (number 095066 ), and grants from the Bill & Melinda Gates Foundation ( OPP1119467 , OPP1093011 , OPP1106023 , and OPP1132415 ). HHN and BSRP are funded by the European Research Council through the Advanced Investigator Grant Momentum (number 324247 ). EON is supported by a grant from the National Institutes of Health (number K01ES025438 ). DLS and AJT are funded by the National Institutes of Health and National Institute of Allergy and Infectious Diseases (number U10AI089674 ), and the Bill & Melinda Gates Foundation (AJT: number OPP1106427 and 1032350, DLS: number OPP1110495 ). AJT is also supported by a Wellcome Trust Sustaining Health Grant (number 10688/Z/15/Z ). JSB acknowledges funding from the National Institutes of Health (# 5R01LM010812-06 ). This study was made possible by the support of the American people through the United States Agency for International Development Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative Agreement number AID-OAA-A-14-00102 ), which supports OGP and MUGK. SC acknowledges funding from the French Government's Investissement d'Avenir program , Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (number ANR-10-LABX-62-IBEID ), the NIGMS MIDAS initiative , the AXA Research Fund , and the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 278433 (PREDEMICS, EU program ZikAlliance)., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), European Project: 281803,EC:FP7:HEALTH,FP7-HEALTH-2011-single-stage,IDAMS(2011), European Project: 634650,H2020,H2020-PHC-2014-two-stage,VIROGENESIS(2015), European Project: 324247,EC:FP7:ERC,ERC-2012-ADG_20120411,MOMENTUM(2013), European Project: 278433,EC:FP7:HEALTH,FP7-HEALTH-2011-two-stage,PREDEMICS(2011), Salje, Henrik [0000-0003-3626-4254], Apollo - University of Cambridge Repository, University of Oxford [Oxford], Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), University of California [San Francisco] (UCSF), University of California, Harvard University [Cambridge], and University of KwaZulu-Natal (UKZN)